Pfizer Ltd. — Regulatory Filings 2021

Aug 20, 2021

Pfizer Limited

The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

August 20, 2021

The Corporate Relationship Dept. BSE Limited 1st Floor, P.J.Towers Dalal Street, Fort Mumbai – 400 001 Scrip Code: 500680

The Manager, Listing Dept. The National Stock Exchange of India Ltd. Exchange Plaza, 5th Floor, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E) Mumbai – 400 051 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Proceedings of the 70th Annual General Meeting – Pfizer Limited

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed proceedings of the 70th Annual General Meeting of the Company held on August 19, 2021.

We request you to kindly take the same on record.

Thanking you,

Yours truly,

For Pfizer Limited

Prajeet Nair Company Secretary

Pfizer Limited

The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

Fair Summary of Proceedings of the 70th Annual General Meeting of Pfizer Limited held on Thursday, August 19, 2021 at 3.00 p.m (IST) through Video Conferencing (''VC'') / Other Audio-Visual Means ("OAVM").

• 1. The 70th Annual General Meeting of the Members of Pfizer Limited was held on Thursday, August 19, 2021 at 3.00 p.m through Video Conferencing ("VC") / Other Audio-Visual Means ("OAVM"). The Meeting commenced at 3.00 p.m and concluded at 5.30 p.m.
• 1. Mr. R. A Shah, Independent Director, chaired the Annual General Meeting from the Registered Office of the Company.
• 1. The Managing Director Mr. S. Sridhar, the Executive Director (Finance) & Chief Financial Officer – Mr. Milind Patil, the Executive Director (Legal) – Mr. Samir Kazi and the Company Secretary – Mr. Prajeet Nair attended the Annual General Meeting from the Registered Office of the Company.
• 1. The Independent Directors, Mr. Pradip Shah, Mr. Uday Khanna, Mr. Sunil Lalbhai and Ms. Meena Ganesh attended the Meeting from their respective residences.
• 1. The Statutory Auditors and Secretarial Auditor also attended the Meeting via Video Conferencing.
• 1. The requisite quorum being present, the Chairman called the Meeting to order.
• 1. Mr. R. A. Shah informed that in view of the continuing Covid-19 pandemic, the Meeting was held through VC/ OAVM in compliance with the circulars issued by the Ministry of Corporate Affairs, Government of India and Securities and Exchange Board of India.
• 1. Mr. R. A. Shah further informed about the representations received from Corporate Shareholders. As the Meeting was conducted virtually without the presence of members in person, the Proxy facility was not necessitated and accordingly had not been provided. Further the registers as required under Companies Act, 2013 were available for inspection in electronic mode.
• 1. Mr. R. A. Shah then introduced all the Members attending the Meeting from the Registered Office of the Company and through Video Conferencing from their respective locations.
• 1. Mr. Prajeet Nair thereafter explained certain guidelines regarding participation at the Annual General Meeting.
• 1. Mr. Prajeet Nair stated that under the Companies Act, 2013, remote e-voting on the proposed resolutions contained in the notice of the Annual General Meeting was mandatory and same had been provided by the Company. Mr. Bhumitra Dholakia, Designated Partner of Dholakia & Associates LLP, Company Secretaries had been appointed as a Scrutinizer for remote e-voting and e-voting at this Annual General Meeting.
• 1. Mr. R. A. Shah then delivered the Chairman's Speech to the Shareholders.
• 1. Mr. S. Sridhar, Managing Director thereafter made a presentation to the Members giving an overview of the Pharmaceutical Industry, Indian Economy, Company's Performance in FY 2020-21 and Q1 2021-22.
• 1. With the consent of the Members, the Notice Convening the 70th Annual General Meeting, having been circulated to all the Members, was taken as read.
• 1. Since there was no qualification in the Independent Auditors' Report, the same was not required to be read and with the permission of the Members, Independent Auditor's Report was taken as read.
• 1. The Chairman then took up the Agenda according to the Notice. He informed the Members that the Managing Director would be responding to the questions of the Members.
• 1. The Chairman then read the business agenda items which the Company proposed to transact vide the Notice of the 70th Annual General Meeting.

Ordinary Business:

• I. To receive, consider and adopt the Audited Financial Statement of the Company for the Financial year ended March 31, 2021, together with the Reports of the Board of Directors and Auditors there on. – Ordinary Resolution.
• II. To declare a dividend of Rs. 35 (350%) per equity share for the financial year ended March 31, 2021. – Ordinary Resolution.
• III. To appoint a Director in place of Mr. Samir Kazi (DIN: 07184083), who retires by rotation and being eligible, offers himself for re-appointment. – Ordinary Resolution.

Special Business:

• IV. To consider re-appointment of Mr. S. Sridhar (DIN: 05162648) as the Managing Director of the Company effective March 18, 2021 – Ordinary Resolution.
• V. To consider and ratify remuneration payable to Messrs. RA & Co., Cost Accountants for the financial year ending March 31, 2022 – Ordinary Resolution.
• 1. The Chairman thereafter informed the Members that e-voting window was already opened and shall be kept open till 15 minutes from the conclusion of this Meeting.
• 1. The Shareholders were informed that the results of the remote e-voting and e-voting conducted at Annual General Meeting would be declared within 2 working days from the conclusion of the Annual General Meeting.
• 1. The Meeting was thereafter concluded by the Chairman.

Thanking You,

Yours Truly, For PFIZER LIMITED

Prajeet Nair Company Secretary

Date: August 20, 2021